News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Clinical Trial Delays Hit Lipoxen (LPX.L) Revenues


2/5/2010 10:23:22 AM

Bookmark and Share

IB Times -- Bio-pharmaceutical firm Lipoxen's revenues were below its expectations in the second half of 2009. It said this was due to a delay in the phase II clinical trials for long-acting EPO and Insulin which meant the potential licensing revenues accompanying these candidates did not materialise.

Read at News Release


comments powered by Disqus
Lipoxen
 
 
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES